Ubs Oconnor LLC En V Veno Medical Corp Transaction History
Ubs Oconnor LLC
- $2.23 Billion
- Q2 2025
A detailed history of Ubs Oconnor LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 241,161 shares of NVNO stock, worth $168,812. This represents 0.04% of its overall portfolio holdings.
Number of Shares
241,161Holding current value
$168,812% of portfolio
0.04%Shares
12 transactions
Others Institutions Holding NVNO
# of Institutions
40Shares Held
5.29MCall Options Held
29KPut Options Held
0-
Perceptive Advisors LLC New York, NY1.28MShares$899,4760.23% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY859KShares$601,4820.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA698KShares$488,8370.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$416,2620.1% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$280,8403.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $6.63M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...